Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026)
Natera's (NTRA) quarterly Net Income towards Common Stockholders came in at -$66.9 million in Q2 2026, up 33.71% on a YoY basis from -$50.1 million in Q2 2025, and up 21.36% quarter-over-quarter from -$85.1 million in Q1 2026.
Analysis
Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Net Income towards Common Stockholders for 13 consecutive years, with -$66.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 33.71% year-over-year to -$66.9 million; the trailing twelve-month figure through Jun 2026 stood at -$192.3 million (up 9.6% YoY), and the FY2025 full-year result was -$208.2 million, down 38.88% from the prior year.
- Net Income towards Common Stockholders improved to -$66.9 million in Q2 2026 per NTRA's latest filing, from -$85.1 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $47.3 million in Q4 2025 and bottomed at -$145.2 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$77.8 million across 5 years, with a median of -$86.3 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders plunged 197.71% in 2024, then jumped 458.85% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$142.6 million in 2022, then surged by 109.46% to $13.5 million in 2023, then slumped by 197.71% to -$13.2 million in 2024, then surged by 458.85% to $47.3 million in 2025, then tumbled by 241.49% to -$66.9 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$66.9 million, -$85.1 million, and $47.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -66.93 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 324.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 8.51 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -637,000.00 |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -16.21 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -381,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.93 Mn |
| Mar 31, 2026 | -85.11 Mn |
| Dec 31, 2025 | 47.30 Mn |
| Sep 30, 2025 | -87.54 Mn |
| Jun 30, 2025 | -100.96 Mn |
| Mar 31, 2025 | -66.96 Mn |
| Dec 31, 2024 | -13.18 Mn |
| Sep 30, 2024 | -31.59 Mn |
| Jun 30, 2024 | -37.47 Mn |
| Mar 31, 2024 | -67.60 Mn |
| Dec 31, 2023 | 13.49 Mn |
| Sep 30, 2023 | -109.03 Mn |
| Jun 30, 2023 | -110.80 Mn |
| Mar 31, 2023 | -136.94 Mn |
| Dec 31, 2022 | -142.57 Mn |
| Sep 30, 2022 | -121.48 Mn |
| Jun 30, 2022 | -145.15 Mn |
| Mar 31, 2022 | -138.60 Mn |
| Dec 31, 2021 | -140.56 Mn |
| Sep 30, 2021 | -151.27 Mn |